German pharmaceutical company Boehringer Ingelheim has signed a long-term agreement with software company MDL Information Systems to use its software technology for managing and deploying chemical information systems.
The agreement covers a package of MDL Discovery Framework technology, including MDL Relational Chemistry Server, MDL's data cartridge technology for searching molecules and reactions stored directly in Oracle databases. The aim being that software developers at Boehringer Ingelheim can manage fully relational reaction and molecule structure databases while integrating corporate data in an open Oracle environment.
"We're very pleased with Boehringer Ingelheim's choice of MDL Discovery Framework technology as the foundation for their research systems," said Lars Barfod, executive vice president and chief business officer for MDL. "We're confident that the seamless access to Oracle-based enterprise data and the tremendous flexibility that MDL Relational Chemistry Server offers will become invaluable assets to their discovery efforts."
In addition to the MDL Relational Chemistry Server, the agreement includes MDL ISIS (Integrated Scientific Information System) and MDL Chemistry Rules Interface, a chemical scripting language and environment for building, validating, and applying rules to consistently analyze and interpret chemistry.